{"database": "lobbying", "table": "lobbying_activities", "rows": [[1413560, "c99e0cb8-633b-45c1-9e0d-3916973e4d59", "Q2", "PRIME POLICY GROUP", 400532589, "GLAXOSMITHKLINE", 2013, "second_quarter", "PHA", "Hearing in Energy and Commerce Committee. Drug supply chain.", "HOUSE OF REPRESENTATIVES", 40000, null, 0, 0, "2013-07-18T15:10:15.237000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1413560"], "units": {}, "query_ms": 11.53351308312267, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}